Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
All inquiries are unique, and the doctor must examine the patient before recommendations can be made
And women can choose microdose, standard dose, oral options, or taper plans based on how they respond rather than how the software dictates
Waist-to-Hip Ratio for Men Men are more likely to store fat in the abdominal area
doi: 10.1002/ijc.25938
HOW TO USE
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
US$ 21.39
US$ 24.18
US$ 28.18
US$ 23.84
